Seattle-based Fred Hutch Cancer Center named Nicole Fleming, MD, as its inaugural deputy chief medical officer.
The Latest
When diagnosed with prostate cancer, men with limited life expectancy are being overtreated, according to a study published Nov. 11 in JAMA Internal Medicine.
Among the many factors at play in overcoming cancer care gaps in the U.S., increased screening and access to care are top of mind. However, cancer trial participation is also crucial.
An FDA advisory panel endorsed a minimally invasive breast cancer surgery alternative at a Nov. 7 meeting.
Research and innovation have steadily driven advancements in breast cancer screening since Congress enacted the Mammography Quality Standards Act in 1992.
Houston-based University of Texas MD Anderson Cancer Center has launched the Institute for Cell Therapy Discovery & Innovation. Research at the institute will focus on immunology and cell engineering with the purpose of creating new treatments for cancer and autoimmune…
Altamonte Springs, Fla.-based AdventHealth has launched a pilot program designed to harness AI to assess a patient's risk of developing breast cancer.
A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial.
Seattle-based Fred Hutch Cancer Center and NASA have partnered on a pediatric cancer program that aims to alleviate patient fears about radiation therapy.
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center had the lowest rate of methicillin-resistant Staphylococcus aureus infections for hospitals exempt from reporting to Medicare's Inpatient Prospective Payment System.